
CRISPR gene editing is transforming medicine by targeting the genetic roots of inherited diseases once thought untreatable. While eliminating all hereditary disorders within a generation remains unlikely, scientists are making remarkable progress against conditions like sickle cell disease and β-thalassemia, bringing humanity closer than ever to rewriting its genetic future. Read more

CRISPR 2.0 represents a major leap in gene editing technology, allowing scientists to modify DNA without breaking both strands. Developed through breakthroughs in base editing and prime editing since 2016, this next-generation approach promises safer genetic corrections and new treatments for inherited diseases once considered untreatable. Read more

Large Language Models are transforming drug discovery by analyzing massive biological data, designing molecules, and predicting drug safety faster than ever before. With major companies investing billions and AI-designed drugs already entering clinical trials, this technology is reshaping how medicines are discovered, tested, and developed across global research laboratories. Read more